Triple Negative Breast Cancer

Showing 26 - 50 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

Looking At Triple Negative Breast Cancer Patient Experience

Not yet recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
    • (no location specified)
    Mar 3, 2023

    Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
    • (no location specified)
    Feb 28, 2023

    Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • NM1F Injection
    • Pembrolizumab injection
    • (no location specified)
    Feb 23, 2023

    Patient Decision Making in Early Stage Breast Cancer:Conjoint

    Recruiting
    • Triple Negative Breast Cancer
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Feb 14, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • Imatinib 400 MG Oral Tablet
      • Gothenburg, Sweden
        Barbro Linderholm
      Feb 1, 2023

      Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

      Not yet recruiting
      • Advanced Cancer
      • +16 more
      • Fosifloxuridine Nafalbenamide
      • +3 more
      • Birmingham, United Kingdom
      • +3 more
      Feb 1, 2023

      Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

      Recruiting
      • Ovarian Cancer
      • +8 more
      • Scottsdale, Arizona
      • +11 more
      Jan 31, 2023

      Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

      Recruiting
      • Triple Negative Breast Cancer
      • +14 more
      • LYL797
      • Scottsdale, Arizona
      • +10 more
      Jan 30, 2023

      Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

      Recruiting
      • Triple Negative Breast Cancer
      • Breast Cancer
      • Fairway, Kansas
      • +5 more
      Jan 26, 2023

      Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

      Recruiting
      • Triple Negative Breast Cancer
      • Sacituzumab govitecan-hziy (SG)
      • +2 more
      • Glendale, Arizona
      • +7 more
      Jan 26, 2023

      Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

      Active, not recruiting
      • Triple Negative Breast Cancer
      • Breast Cancer
      • Los Alamitos, California
      • +6 more
      Jan 25, 2023

      Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

      Recruiting
      • Triple Negative Breast Cancer
      • +5 more
      • Orange, California
      • +6 more
      Jan 23, 2023

      Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Metastatic Breast Cancer
      • Sacituzumab govitecan
      • (no location specified)
      Jan 23, 2023

      Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

      Recruiting
      • Triple Negative Breast Cancer
      • HER2-positive Breast Cancer
      • proton plus carbon ion radiotherapy
      • Shanghai, China
        Shanghai Proton and Heavy Ion center
      Jan 11, 2023

      Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,

      Recruiting
      • Triple Negative Breast Cancer
      • PD-L1 Negative
      • Sacituzumab Govitecan-hziy
      • +4 more
      • Anchorage, Alaska
      • +231 more
      Jan 17, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

      Recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • Washington, District of Columbia
      • +5 more
      Jan 12, 2023

      Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,

      Recruiting
      • Triple Negative Breast Cancer
      • PD-L1 Positive
      • Sacituzumab Govitecan-hziy
      • +5 more
      • Anchorage, Alaska
      • +245 more
      Jan 12, 2023

      Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

      Recruiting
      • Triple Negative Breast Cancer
      • HER2-negative Breast Cancer
      • HER2 - primed Dendritic cells
      • HER3 - primed Dendritic cells
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 10, 2023

      Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

      Not yet recruiting
      • Breast Cancer Female
      • Triple Negative Breast Cancer
      • quercetin, EGCG, metformin , zinc
      • (no location specified)
      Dec 23, 2022

      Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

      Recruiting
      • Non Small Cell Lung Cancer
      • +11 more
      • Denver, Colorado
      • +3 more
      Jan 10, 2023

      Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

      Recruiting
      • Triple Negative Breast Cancer
      • +5 more
      • Manchester, Greater Manchester, United Kingdom
      • +6 more
      Jan 5, 2023

      NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

      Recruiting
      • Non-small Cell Lung Cancer
      • +11 more
      • Birmingham, Alabama
      • +32 more
      Jan 4, 2023

      Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple

      Recruiting
      • Triple Negative Breast Cancer
        • New Haven, Connecticut
        • +2 more
        Jan 4, 2023